Diabetic Cardiomyopathies Clinical Trial
Official title:
Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure (ARISE-HF): A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic Cardiomyopathy at high risk of progression to overt heart failure.
The study consists of two consecutive parts: Part A and Part B. Part A will evaluate the safety and efficacy of two doses of AT-001 vs placebo. The primary objective of Part A is to demonstrate that AT-001 improves or prevents the decline of functional capacity in patients with Diabetic Cardiomyopathy. Part B is an extension of at least 12 months that will evaluate the safety and efficacy of chronic administration of AT-001 vs placebo in the same patients who had previously been evaluated in Part A. Assessments in Part B will include safety endpoints and exploratory clinical efficacy endpoints, i.e. death and hospitalization due to a cardiac event. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05556005 -
Efficacy of Trimetazidine in Diabetic Patients
|
Phase 2 | |
Completed |
NCT03299790 -
Effect of High-intensity Interval Training on Cardiac Function and Regulation of Glycemic Control in Diabetic Cardiomyopathy
|
N/A | |
Recruiting |
NCT03132129 -
Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
|
||
Recruiting |
NCT04593173 -
Diabetic Cardiomyopathy
|
||
Not yet recruiting |
NCT04534894 -
Single-center Clinical Study of Early Diagnosis of Diabetic Cardiomyopathy With FLIM
|
||
Terminated |
NCT04141475 -
Evaluation of Alpha-Lipoic Acid in Diabetic Cardiomyopathy
|
N/A | |
Completed |
NCT03049228 -
In and ex Vivo Mitochondrial Function of the Heart
|
||
Completed |
NCT03930004 -
Preclinical Cardiomyopathy and Autonomic Function in Type 1 Diabetes
|
||
Not yet recruiting |
NCT05571865 -
Diabetic Cardiomyopathy and Heart Failure
|
N/A | |
Recruiting |
NCT05958706 -
Mitochondrial Substrate Utilization in the Diabetic Human Heart
|
||
Recruiting |
NCT04591639 -
The DAPA-MEMRI Trial
|
N/A | |
Recruiting |
NCT04826159 -
IMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpEF (Pt 2)
|
Phase 2 | |
Enrolling by invitation |
NCT05915260 -
CMR in T2DM: The NSR Cohort
|